Back to today’s briefing

Story perspectives

New RNA Biomarker CUL1-IPA Linked to Aggressive Blood Cancers

4/12/2026

41 8 Full Breakdown

Summary

Story summary

Researchers at Texas A&M University Health Science Center discovered a ribonucleic acid called CUL1-IPA that helps maintain the nucleolus and regulates cellular activity.
The RNA derives from the CUL1 gene and is linked to survival outcomes in blood cancers such as multiple myeloma and chronic lymphocytic leukemia.
Higher levels of CUL1-IPA correlate with more aggressive cancer forms, suggesting it could be a biomarker and a treatment target.

1 of 1

Story summary

Researchers at Texas A&M University Health Science Center discovered a ribonucleic acid called CUL1-IPA that helps maintain the nucleolus and regulates cellular activity.
The RNA derives from the CUL1 gene and is linked to survival outcomes in blood cancers such as multiple myeloma and chronic lymphocytic leukemia.
Higher levels of CUL1-IPA correlate with more aggressive cancer forms, suggesting it could be a biomarker and a treatment target.